Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Climb Bio, Inc. | 500,000 | reported | 13 Jan 2025 | tx 3+1,042,500 |
| Compass Therapeutics, Inc. | 30,000 | reported | 18 Feb 2022 | tx 2+90,000 |
| Prevail Therapeutics Inc. | 0 | reported | 22 Jan 2021 | tx 4+95,000−506,569 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Jan 2025 | GRANT_AWARD | Climb Bio, Inc. | 500,000 | 0.00 USD | deriv |
| 26 Aug 2024 | GRANT_AWARD | Climb Bio, Inc. | 465,000 | 0.00 USD | deriv |
| 26 Aug 2024 | GRANT_AWARD | Climb Bio, Inc. | 77,500 | 0.00 USD | deriv |
| 18 Feb 2022 | GRANT_AWARD | Compass Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 22 Jan 2021 | OTHER | Prevail Therapeutics Inc. | 347,004 | 0.00 USD | deriv |
| 22 Jan 2021 | OTHER | Prevail Therapeutics Inc. | 64,565 | 0.00 USD | deriv |
| 22 Jan 2021 | OTHER | Prevail Therapeutics Inc. | 95,000 | 0.00 USD | deriv |
| 10 Sept 2020 | GRANT_AWARD | Compass Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 19 Feb 2020 | GRANT_AWARD | Prevail Therapeutics Inc. | 95,000 | 0.00 USD | deriv |